INTERNATIONAL PATENT: SHANGHAI JMT-BIO TECHNOLOGY CO., LTD., 上海津曼特生物科技有限公司 FILES APPLICATION FOR "COMBINED DRUG CONTAINING ANTI-EGFR ANTIBODY OR FRAGMENT THEREOF"

GENEVA, Sept. 16 -- SHANGHAI JMT-BIO TECHNOLOGY CO., LTD. (Room 1002, 10th Floor, No. 380, Fenglin Road, Xuhui DistrictShanghai 200032), 上海津曼特生物科技有限公司 (中国上海市徐汇区枫林路380号10层1002室) filed a patent application (PCT/CN2025/080922) for "COMBINED DRUG CONTAINING ANTI-EGFR ANTIBODY OR FRAGMENT THEREOF" on Mar 06, 2025. With publication no. WO/2025/185682, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World...